A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,768,317 shares of CDMO stock, worth $12.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,768,317
Previous 509,831 246.84%
Holding current value
$12.6 Million
Previous $3.31 Million 257.59%
% of portfolio
0.03%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $7.37 Million - $11.1 Million
1,258,486 Added 246.84%
1,768,317 $11.8 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $1.46 Million - $3.01 Million
314,757 Added 161.35%
509,831 $3.31 Million
Q3 2023

Nov 14, 2023

BUY
$9.4 - $14.04 $1.83 Million - $2.74 Million
195,074 New
195,074 $1.84 Million
Q3 2022

Nov 14, 2022

BUY
$15.33 - $20.36 $5.39 Million - $7.16 Million
351,890 Added 273.63%
480,490 $9.19 Million
Q2 2022

Aug 15, 2022

SELL
$11.63 - $21.55 $2.12 Million - $3.94 Million
-182,639 Reduced 58.68%
128,600 $1.96 Million
Q1 2022

May 16, 2022

BUY
$16.63 - $27.73 $5.18 Million - $8.63 Million
311,239 New
311,239 $6.34 Million
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $6.39 Million - $10.6 Million
-308,780 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $409,194 - $608,313
21,480 Added 7.48%
308,780 $6.66 Million
Q2 2021

Aug 16, 2021

BUY
$18.93 - $25.65 $5.44 Million - $7.37 Million
287,300 New
287,300 $7.37 Million
Q1 2021

May 17, 2021

SELL
$11.86 - $21.77 $1.06 Million - $1.95 Million
-89,563 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $649,331 - $1.05 Million
89,563 New
89,563 $1.03 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $444M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.